Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure (Q48103903)

8 February 2018

title

Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure (English)

1 reference

https://api.crossref.org/works/10.1007/S00380-009-1201-Y

14 June 2024

main subject

heart failure

0 references

chronic heart failure

1 reference

Hisashi Kimura

1

1 reference

8 February 2018

Shinya Hiramitsu

2

1 reference

8 February 2018

Kenji Miyagishima

3

1 reference

8 February 2018

Kazumasa Mori

4

1 reference

8 February 2018

Ryuji Yoda

5

1 reference

8 February 2018

Shigeru Kato

6

1 reference

8 February 2018

Yasuchika Kato

7

1 reference

8 February 2018

Shin-ichiro Morimoto

8

1 reference

8 February 2018

Hitoshi Hishida

9

1 reference

8 February 2018

Yukio Ozaki

10

1 reference

8 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

20676839

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20676839

14 June 2024

publication date

31 July 2010

1 reference

8 February 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00380-009-1201-y.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00380-009-1201-Y

http://link.springer.com/article/10.1007/s00380-009-1201-y/fulltext.html

14 June 2024

1 reference

https://api.crossref.org/works/10.1007/S00380-009-1201-Y

http://link.springer.com/content/pdf/10.1007/s00380-009-1201-y

14 June 2024

1 reference

https://api.crossref.org/works/10.1007/S00380-009-1201-Y

14 June 2024

1 reference

8 February 2018

volume

25

1 reference

8 February 2018

issue

4

1 reference

8 February 2018

page(s)

306-312

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s00380-009-1201-y

exact match

0 references

cites work

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Predictors of mortality and morbidity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Heart failure with preserved systolic function. A different natural history?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Anemia as a risk factor and therapeutic target in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Anemia in chronic kidney disease and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Anaemia and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1201-Y

Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes

21 January 2018

1 reference

12 December 2020

The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?

1 reference

12 December 2020

Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: the GREECS study

1 reference

12 December 2020

The cardio-renal anaemia syndrome: does it exist?

1 reference

12 December 2020

Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function

1 reference

12 December 2020

Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study

1 reference

12 December 2020

Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan

1 reference

12 December 2020

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

1 reference

12 December 2020

Identifiers

1 reference

8 February 2018

PubMed ID

20676839

1 reference

8 February 2018